About Zoetis
Zoetis is a company based in Brussels (Belgium) founded in 2012. Zoetis has completed 16 acquisitions, including Abaxis, Basepaws and Ethos Diagnostic Science. Zoetis offers products and services including Librela, Simparica TRIO, Apoquel, Solensia, and Draxxin KP. Zoetis operates in a competitive market with competitors including Ceva, PetMedix, QBiotics, Hester Biosciences and Bio-Sourcing, among others.
- Headquarter Brussels, Belgium
- Stage Public
-
Sectors
HealthcareAgriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Zoetis Services Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$15.3 M (USD), Grant
Mar 01, 2023
-
Investors
Gates Foundation
& 1 more
-
Employee Count
Not available
-
Investments & Acquisitions
Abaxis
& 15 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Zoetis
Zoetis is a publicly listed company on the NYSE with ticker symbol ZTS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Zoetis
Zoetis offers a comprehensive portfolio of products and services, including Librela, Simparica TRIO, Apoquel, Solensia, and Draxxin KP.
Treatment for canine osteoarthritis pain relief
Protection against parasites in dogs
Manages allergic skin conditions in dogs
Therapy for pain in cats
Antibiotic for cattle respiratory diseases
People of Zoetis
Unlock access to complete
Unlock access to complete
Software Development Team
282 people
Leadership Team
150 people
Senior Team
82 people
Sales and Marketing
76 people
Product Management Team
48 people
Principal Team
37 people
Operations Team
33 people
Human Resources and Administration
28 people
Unlock access to complete
Funding Insights of Zoetis
Investors in Zoetis
Zoetis has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Gates Foundation and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Charitable foundation investments on poverty reduction and healthcare
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Zoetis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zoetis
Zoetis has strategically engaged in corporate development activities, having acquired 16 companies. Notable acquisitions include Abaxis, Basepaws and Ethos Diagnostic Science.
Investment portfolio details for Zoetis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Species-specific antibodies for pets are developed via a specialized platform.
|
Locked | Locked | 2018 | Locked | |
|
Developer of monoclonal antibody therapeutics for pets
|
Locked | Locked | 2017 | Locked | |
|
Provider of veterinary medicines, vaccines & diagnostic products supplying services
|
Locked | Locked | 2017 | Locked |
Complete acquisition details for Zoetis
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Zoetis
Detailed financials for Zoetis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zoetis Comparisons
Peer comparison for Zoetis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Zoetis
Zoetis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ceva, PetMedix, QBiotics, Hester Biosciences and Bio-Sourcing, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Animal health therapeutics are developed and supplied globally by Ceva.
|
|
| Locked | Locked | Locked |
Developer of monoclonal antibody therapeutics for pets
|
|
| Locked | Locked | Locked |
Small molecules from plant extracts are developed for medical applications.
|
|
| Locked | Locked | Locked |
Manufacturer of animal vaccines and healthcare products
|
|
| Locked | Locked | Locked |
Biopharmaceuticals for animals are manufactured and supplied through partnerships.
|
Detailed competitors of Zoetis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zoetis
Complete news archive for Zoetis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zoetis
Zoetis was founded in 2012 and raised its 1st funding round 3 years after it was founded.
Zoetis is headquartered in Brussels, Belgium. It is registered at Brussels, Brussels-capital Region, Belgium.
Zoetis was founded in 2012 and is based in Brussels, Belgium. Operations focus on the animal health sector, where medicines, vaccines, and diagnostic products are developed and distributed for livestock including poultry, swine, sheep, horses, and cattle. Solutions target disease prevention and treatment in respiratory, gastrointestinal, and reproductive systems. Additional offerings include parasiticides, anti-infectives for microbial issues, medicinal feed additives, and products for pain management and sedation.
Zoetis offers Librela, Simparica TRIO, Apoquel, Solensia, and Draxxin KP.
Yes, Zoetis is publicly traded on NYSE under the ticker symbol ZTS.
Zoetis has made 16 acquisitions, including Abaxis, Basepaws, and Ethos Diagnostic Science.
Zoetis has 2 investors. Key investors include Gates Foundation, and European Union.
The ticker symbol of Zoetis is ZTS on NYSE.